Production (Stage)
Repligen Corporation
RGEN
$122.78
$4.633.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.97% | 8.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.97% | 8.18% | |||
| Cost of Revenue | -10.81% | 14.93% | |||
| Gross Profit | 13.77% | 1.70% | |||
| SG&A Expenses | 84.08% | -48.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.73% | -14.24% | |||
| Operating Income | -69.23% | 756.28% | |||
| Income Before Tax | 120.57% | -3,260.14% | |||
| Income Tax Expenses | 144.59% | -857.37% | |||
| Earnings from Continuing Operations | 117.21% | -5,078.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 117.21% | -5,078.75% | |||
| EBIT | -69.23% | 756.28% | |||
| EBITDA | -42.64% | 285.77% | |||
| EPS Basic | 117.20% | -5,064.10% | |||
| Normalized Basic EPS | -62.25% | 1,518.78% | |||
| EPS Diluted | 116.40% | -5,111.11% | |||
| Normalized Diluted EPS | -62.53% | 1,518.78% | |||
| Average Basic Shares Outstanding | 0.12% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.89% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||